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Abstract 
As a cheap and safe antimalarial agent, chloroquine (CQ) has been used in the 
battle against malaria for more than half century. However, the mechanism of 
CQ action and resistance in Plasmodium falciparum remains elusive. Based 
on further analysis of our published experimental results, we propose that the 
mechanism of CQ action and resistance might be closely linked with cell-cycle- 
associated amplified genomic-DNA fragments (CAGFs, singular form = CAGF) 
as CQ induces CAGF production in P. falciparum, which could affect multiple 
biological processes of the parasite, and thus might contribute to parasite 
death and CQ resistance. Recently, we found that CQ induced one of CAGFs, 
UB1-CAGF, might downregulate a probable P. falciparum cystine transporter 
(Pfct) gene expression, which could be used to understand the mechanism of 
CQ action and resistance in P. falciparum. 
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1. Introduction 
Chloroquine (CQ) was developed in 1930’s, and has been the mainstay of ma-
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laria chemotherapy for many decades. CQ resistance in Plasmodium falciparum 
first appeared in Thailand in 1957 and now is widespread in nearly all P. falci-
parum malaria endemic areas of the world [1]. Although CQ’s value in malaria 
chemotherapy has diminished due to CQ resistance in P. falciparum, CQ’s story 
continues as in recent years CQ has been found to enhance efficacy of various 
anticancer drugs [2], signifying renaissance of this old miracle drug. 
However, to date, the mechanism of CQ action and resistance in P. falciparum 
remains controversial. Briefly, there are two main hypotheses regarding the 
mechanism of CQ action and resistance in P. falciparum, one could be named as 
the food-vacuole hypothesis that states that CQ’s action site is the food vacuole 
in which toxic heme resulted from CQ’s blockade of hemozoin formation kills 
malaria parasite and the food-vacuole membrane proteins, pfmdr1 and pfcrt, are 
responsible for CQ resistance [3]; another could be named as the nucleus hy-
pothesis that claims that CQ’s action site is the nucleus in which CQ causes 
DNA damage through DNA intercalation or apoptosis [4] [5] and defective 
DNA repair and alteration in DNA damage regulation might also contribute to 
CQ resistance [6] [7]. We once proposed that the key site of CQ action and re-
sistance development is the nucleus of malaria parasite [8] and P. falciparum CQ 
resistance marker protein (Pfcrmp) might be the CQ’s target in the nucleus [9] 
[10]. Recently, we reported that P. falciparum produces cell-cycle-associated 
amplified genomic-DNA fragments (CAGFs) at certain points of its intraeryth-
rocytic cycle, and CQ can induce CAGF production [11]. In this paper, we pre-
sent the results of further analysis of these findings, which might contribute to 
understanding the mechanism of CQ action and resistance in P. falciparum. 
2. The Hypothesis 
Based on further analysis of our published experimental results, we propose that 
the mechanism of CQ action and resistance in P. falciparum might be closely 
linked with cell-cycle-associated amplified genomic-DNA fragments (CAGFs, 
singular form = CAGF) as CQ induces CAGF production in P. falciparum, 
which could affect multiple biological processes of the parasite, and thus might 
contribute to parasite death and CQ resistance. 
3. Background of Discovery of Cell-Cycle-Associated  
Amplified Genomic-DNA Fragments (CAGFs) 
Cell-cycle-associated amplified genomic-DNA fragments (CAGFs) were discov-
ered purely by chance [11]. Briefly, about 18 years ago, in order to check whe- 
ther CQ could cause DNA damage in P. falciparum, both CQ-sensitive HB3 iso-
late, and CQ-resistant K1 isolate were treated with different doses of CQ. Para-
site samples were harvested at 2 h, 6 h, 12 h, and 24 h intervals after the start of 
CQ treatment and then genomic DNA from the harvested samples was isolated. 
Using the isolated genomic DNA, we performed arbitrarily-primed PCR with 
one single arbitrary primer, named as AP1. Initially, we thought that if there was 
no DNA damage, the PCR banding patterns should be exactly the same in all 
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samples, and if there was DNA damage the number of PCR bands would be re-
duced as DNA damage means that quantity and quality of DNA templates are 
reduced. As for the control groups, undoubtedly, the PCR banding pattern 
should remain the same in all samples. However, contrary to our anticipation, 
the PCR banding patterns in both control and CQ treated groups exhibited 
cell-cycle dependent changes, which was caused by two unstable bands, UB1 and 
UB2. In the control groups of both HB3 and K1 isolates, UB2 and UB1 appeared 
at 6 h and 12 h, respectively, whereas in the CQ-treated groups, both UB1 and 
UB2 appeared in the 2h samples of both isolates. Furthermore, both UB1 and 
UB2 in the CQ-treated groups were much clearer than those in the control 
groups, indicating that CQ induces both UB1 and UB2 production in both iso-
lates. Appearance and disappearance of UB1 and UB2 at different points of the 
parasite’s intraerythrocytic cycle suggest that the copy number of UB1- and 
UB2-related DNA templates increased and decreased accordingly during cell- 
cycle progression. This is why we named UB1- and UB2-related templates as 
UB1- and UB2-related CAGFs which can be further simplified as UB1-CAGF 
and UB2-CAGF. Here, the word, “amplified”, refers to multiple copies, and does 
not mean gene or DNA amplification because if UB1- and UB2-related tem-
plates increased due to DNA amplification, the amplified templates would be 
incorporated into the genome and would not disappear few hours later. Besides, 
DNA amplification can not be induced 2 h after the start of CQ treatment. 
Therefore, we speculate that CAGFs are single-stranded DNA (ssDNA) frag-
ments or molecules that are released from the genome into the nucleoplasm. 
Mechanism by which CAGFs are produced and released from the genome is 
unknown, but we have proposed three possible mechanisms which include 
DNA-polymerase dependent DNA to DNA transcription [11] [12], endonucle-
ase dependent transcript cutout [13], and genoautotomy (genome “self-injury”) 
[14]. Originally, we speculated that both endonuclease dependent transcript 
cutout and genoautotomy mainly cut DNA at non-coding DNA region, but now 
we think that active transcription region might be the main target for both of 
them because recently we found UB1 sequence belongs to the coding DNA se-
quence of a gene. In the following section, the UB1-CAGF related gene’s func-
tion and its association with CQ action and resistance in P. falciparum will be 
described in more detail. 
If CAGF mainly comes from the coding DNA region of a gene, there will be 
enormous implications for biological science. First, since CAGF originates from 
coding DNA region, its sequence should be complimentary to either sense or 
antisence-strand sequence of the transcription region, the gene located within 
this transcription region could be named as CAGF-related gene. Thus, as a 
ssDNA molecule, CAGF can downregulate CAGF-related gene expression through 
either antisense or antigene or both strategies [15]; second, if CAGF generation 
is through endonuclease dependent transcript cutout [13] or genoautotomy 
(genome “self-injury”) [14], a transient ssDNA gap caused by releasing CAGF 
will be formed at transcription region before complete repair of the gap. Both 
CAGF and ssDNA gap belong to ssDNA that is more prone to mutations than 
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double-stranded DNA [16]. Furthermore, certain small fragments of CAGFs 
could serve as intrinsic mutation-contained primers that might be involved in 
natural site-directed mutagenesis [17]. Therefore, CAGF generation during cell 
cycle might contribute to drug resistance and evolution; third, if CAGFs can be 
released from cell as cell-free DNA (cfDNA) into blood stream in mammals, 
they might serve as mobile genetic elements [18] involved in horizontal or verti-
cal genetic transfer. Since CAGFs might carry both genetic and epigenetic altera-
tions in a gene, they might be involved in inheritance of acquired characteristics 
through vertical genetic transfer. Taken together, CAGFs might have a wide range 
of biological functions, but their main function is downregulation of CAGF-re- 
lated gene expression, which is required for normal cell cycle progression. 
4. Linkage between CAGF and CQ Action and  
Resistance in P. falciparum 
As mentioned above, CAGF’s main function is downregulation of CAGF-related 
gene expression. In our published paper, two CAGFs, i.e. UB1-CAGF and UB2- 
CAGF, were reported, which means that there are two CAGF-related genes, 
UB1-CAGF related gene and UB2-CAGF related gene, which could be down-
regulated by UB1-CAGF and UB2-CAGF, respectively. However, till now, only 
partial UB1-CAGF has been cloned and sequenced, therefore, in this section, we 
mainly focus on the function of a gene downregulated by UB1-CAGF, which 
might contribute to CQ action and resistance in P. falciparum. 
About 18 years ago, we cloned and sequenced UB1 band, the obtained sequence 
shares 80% amino acid similarity with an unknown gene of Escherichia coli 
(P32667). The accession number of P32667 has now been changed to P0ABT8 in 
UniProtKB. Recently, we found that P0ABT8 has been named as probable cystine 
transporter YijE, which suggests that UB1-CAGF comes from the transcription re-
gion which might harbour a probable P. falciparum cystine transporter (Pfct) 
gene. This is a surprising new finding because the gene has not yet been reported 
in P. falciparum so far and might be involved in glutathione (GSH) synthesis. 
The probable cystine transporter YijE gene encodes a membrane protein that 
is involved in response to cystine in E. coli, and overexpression of the protein 
confers tolerance to excess cystine [19]. In eukaryotic cells, the cystine trans-
porter is also called cystine/glutamate antiporter that takes in extracellular cys- 
tine in exchange for intracellular glutamate [20] [21]. P. falciparum belongs to 
eukaryote and thus Pfct should function as a cystine/glutamate antiporter. Since 
uptake of cystine is required for intracellular GSH synthesis [22], Pfct might play 
a critical role not only in intracellular GSH synthesis, but also in GSH mainte-
nance as cystine deprivation can induce GSH efflux and degradation [23]. 
Cystine used for GSH synthesis in P. falciparum might come from haemoglo-
bin digestion in the food vacuole of the parasite. Therefore, it is most likely that 
Pfct is located in the food-vacuole membrane and transports cystine out of the 
food vacuole for GSH synthesis. The synthesized GSH will then be distributed in 
all intracellular compartments including the nucleus to exert its antioxidant and 
other biological effects. 
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CQ action and resistance in P. falciparum might be closely associated with 
Pfct due to two reasons: first, according to our published paper, UB1 and UB2 
bands in the 12 h-HB3 control is much clearer than that in the 12 h-K1 control 
(Figure 1), suggesting that CQ-sensitive HB3 isolate produces more UB1- and 
UB2-CAGFs than CQ-resistant K1 isolate. Less UB1-CAGF induction in K1 iso-
late means more Pfct expression and more GSH synthesis in K1 isolate, which is 
consistent with previous report that levels of total GSH was higher in CQ-resis- 
tant P. falciparum Dd2 isolate than in CQ-sensitive P. falciparum 3D7 isolate 
[24]. Interestingly, increased GSH synthesis is also found in various drug-resis- 
tant cancer cell lines [25]; second, CQ at low dose (25 nM) can effectively induce 
both UB1- and UB2-CAGFs at early stage (2 h) of intraerythrocytic cycle of both 
HB3 and K1 isolates, but there is difference between two isolates in sustainability 
of UB1- and UB2-CAGFs. In K1 isolate, both UB1- and UB2-CAGFs disappeared 
at 12 h, while in HB3 isolate, only UB2-CAGF disappeared at 12 h, indicating 
more degradation of UB1-CAGF in K1 isolate than in HB3 isolate (Table 1). 
 
 
Figure 1. Arbitrarily-primed PCR banding patterns from CQ-sensitive HB3 and CQ-re- 
sistant K1 isolates (from Li, 2016 [11]). M = 100-bp-DNA ladder marker; C = control; CQ 
= chloroquine; UB1 size ≈ 1000 bp; UB2 size ≈ 1150 bp. 
 
Table 1. Appearance (+) and disappearance (−) of UB1 and UB2 in the PCR products 
from the genomic-DNA samples of HB3 and K1 isolates using * indicating difference 
between the two isolates (from Li, 2016 [11]). 
Isolates Treatment PCR bands 2 h 6 h 12 h 24 h Total + 
HB3 
Control UB1 − − + − 4 
 UB2 − + + +*  
CQ (25 nM) UB1 + + +* + 6 
 UB2 + +* − −*  
K1 
Control UB1 − − + − 3 
 UB2 − + + −*  
CQ (25 nM) UB1 + + −* + 5 
 UB2 + −* − +*  
Sampling at 2h (CQ treated)
M C 5nM 25nM M C 25nM
UB1
UB2
UB2
UB1
Sampling at 12h (C)
M HB3 M K1
HB3 K1
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Table 1 shows that more + in HB3 isolate than in K1 isolate, which suggests  
that CQ induced UB1-CAGF downregulated Pfct gene expression in HB3 isolate 
more severely than in K1 isolate. Thus, it can be concluded that overall GSH lev-
els in K1 isolate were higher than those in HB3 isolate during CQ treatment. 
Since GSH plays an important role in antioxidant defence, low GSH levels indi-
cate low antioxidant capacity, which will make the parasite more vulnerable to 
the attack of reactive oxygen species (ROS) that are constantly produced during 
oxidative metabolism and serve as a major contributor to oxidative damage of 
carbohydrates, nucleic acids, lipids, and proteins [26]. Furthermore, GSH deple-
tion can elicit apoptosis and necrosis [27] and depletion of nuclear GSH impairs 
cell proliferation [28]. Taken together, CQ might kill CQ-sensitive P. falciparum 
through inducing UB1-CAGF that downregulates Pfct expression, which de-
creases GSH synthesis, and thus reduces antioxidant capacity, making the para-
site more vulnerable to ROS attack. Among the various oxidative damages 
caused by ROS, DNA damage might contribute largely to parasite death. Less 
production and more degradation or more extracellular release of UB1-CAGF 
might contribute to CQ resistance in P. falciparum. 
Theoretically, if downregulation of Pfct expression by UB1-CAGF is closely 
linked with CQ action, the timing of CQ induced UB1-CAGF should be consis-
tent with the timing of parasite stages on which CQ acts. CQ induced UB1- 
CAGF appeared as early as 2 hours after the start of CQ treatment, which means 
that the parasite development was at the early ring-form stage [29]. If CQ in-
duces UB1-CAGF in the early ring-form stage parasite, Pfct expression in this 
stage will be greatly downregulated, which means less GSH synthesis, and re-
duced antioxidant capacity, and therefore making the stage parasite more vul-
nerable to ROS attack. But previous research shows that the late stages, i.e. tro-
phozoite and schizont, are considerably more sensitive to CQ than ring-stage 
parasites, which is coincident with elevated glucose consumption and nucleic 
acid synthesis [30]. One explanation for this contradiction is that the ring-form 
stage parasite might produce less ROS than late stage parasite due to less glucose 
metabolism as ROS is involved in regulation of glucose metabolism and glucose 
can induce ROS production [31] [32]. The main difference between HB3 and K1 
isolates in CQ’s induction of UB1-CAGF is that CQ induced UB1-CAGF was 
sustained in 12 h-sample of HB3 isolate, but disappeared in 12 h-sample of K1 
isolate (Table 1). Since 12 h-sample is equivalent to late ring-form stage sample, 
it can be speculated that GSH levels in the late ring-form stage of K1 isolate is 
higher than those in the late ring-form stage of HB3 isolate, which can be used to 
understand the reason why K1 isolate is insensitive to CQ treatment. A clinical 
research has shown that CQ acts principally on the large ring-form and mature 
trophozoite stages of P. falciparum [33], which is consistent with our specula-
tion. In conclusion, downregulation of Pfct expression by UB1-CAGF is closely 
linked with CQ action and resistance in P. falciparum. 
Till now, we don’t know what gene is downregulated by UB2-CAGF, however, 
since CQ can also induce UB2-CAGF production, it is possible that UB2-CAGF 
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related gene’s function might also contribute to CQ action and resistance in P. 
falciparum. Besides, in addition to induction of UB1- and UB2-CAGFs, CQ 
might induce other CAGFs in P. falciparum, which needs further investigation. 
We once proposed that P. falciparum CQ resistance marker protein (Pfcrmp) 
was a CQ’s target in the nucleus [9] as the genetic alterations in Pfcrmp gene 
were correlated well with CQ resistance phenotype after checking more than 100 
isolates from three different regions [10]. Pfcrmp’s function is unknown, but 
might be involved in enhancement of histone H3-modulated chromatin struc-
ture which is required for diverse bioprocesses, such as transcription, DNA re-
pair, chromatin compaction during cell division and apoptosis [34]. The reason 
why this assumption is made is because Pfcrmp contains a DNMT1-RFD do-
main that is a potent histone H3 binding domain [35]. Since histone H3 phos-
phorylation is involved in ROS-mediated DNA damage and cell death [36] [37], 
it is possible that binding of CQ to wild-type Pfcrmp might aberrantly induce 
chromatin-structure changes through interaction with histone H3, which will 
make the chromatin DNA vulnerable to ROS attack. CQ might not induce the 
same chromatin-structure changes through interaction with mutant Pfcrmp, 
which contributes to CQ resistance. 
5. Conclusions 
Discoveries of CAGFs and Pfcrmp in P. falciparum strongly support the idea 
that the key site of CQ action and resistance development is within the nucleus 
of malaria parasite. CQ has diverse therapeutic actions, which might be closely 
linked with CQ’s induction of various CAGFs. Since CAGFs might also be pro-
duced and induced by CQ in other eukaryotic cells, such as cancer cells, further 
investigation into this area may not only contribute to understanding the me- 
chanism of CQ action and resistance in both P. falciparum and cancer cells, but 
also helps to design novel drugs and strategies to tackle drug resistance in both 
P. falciaprum and various cancer cells. 
Downregulation of a probable Pfct gene expression by UB1-CAGF is a novel 
mechanism by which intracellular GSH levels are regulated. It has been proved 
by many experimental results that GSH levels are associated with CQ action and 
resistance in the rodent malaria species P. berghei, but the similar convincing 
evidence in P. falciparum has not yet been obtained [38]. No doubt, UB1-CAGF 
modulated Pfct expression supports the view that GSH plays an important role 
in CQ action and resistance in P. falciparum. Unfortunately, 18 years ago, we 
didn’t submit the UB1 DNA sequence to GenBank and now the sequence has 
gone missing. Luckily, the two specific primers we published previously were 
designed based on the sequence [11], which can be used to easily clone this un-
reported Pfct gene. 
CAGFs belong to extrachromosomal ssDNA molecules and their copy num-
bers are increased after CQ treatment [11], which distinguishes them from dou-
ble-stranded extrachromosomal circular DNA (eccDNA) molecules found in all 
eukaryotes [39] [40]. Although eccDNA molecules can be generated by sublethal 
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drug exposure [41] and levels of total eccDNA molecules have been elevated af-
ter exposure of organism to genotoxic agent [42], the copy number of every sin-
gle eccDNA molecule can not be increased after exposure to genotoxic agent be-
cause the formation of eccDNA molecules is through excision of chromosomal 
sequences and no de-novo DNA synthesis is involved [43]. The eccDNA-related 
excision of chromosomal sequences could be considered as a kind of geno-
autotomy in which nonlethal double-stranded genomic-DNA fragments are ex-
cised from chromosomes [14]. 
In conclusion, CQ’s induction of CAGFs in P. falciparum is a very important 
discovery that may open up an entirely new field of research. 
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List of Abbreviations Used in This Article 
CQ   chloroquine 
H   hour 
Pfct   Plasmodium falciparum cystine transporter 
GSH   glutathione 
ROS   reactive oxygen species 
CAGF   cell-cycle-associated amplified genomic-DNA fragment 
UB1   unstable band (UB) 1 in PCR products 
UB2   unstable band (UB) 2 in PCR products 
UB1-CAGF  UB1-related CAGF 
UB2-CAGF  UB2-related CAGF 
Pfcrmp  Plasmodium falciparum chloroquine resistance marker pro-
tein 
DNMT1-RFD DNA (cytosine-5)-methyltransferase 1, replication foci domain 
eccDNA  extrachromosomal circular DNA 
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